MOUNTAINEER-03 phase III study design: First-line mFOLFOX6 + tucatinib + trastuzumab for HER2+ metastatic colorectal cancer Journal Article
| Authors: | Strickler, J. H.; Bekaii-Saab, T.; Cercek, A.; Heinemann, V.; Nakamura, Y.; Raghav, K.; Siena, S.; Tabernero, J.; Van Cutsem, E.; Yoshino, T.; Ramos, J.; Guan, X.; Andre, T. |
| Article Title: | MOUNTAINEER-03 phase III study design: First-line mFOLFOX6 + tucatinib + trastuzumab for HER2+ metastatic colorectal cancer |
| Journal Title: | Future Oncology |
| Volume: | 21 |
| Issue: | 3 |
| ISSN: | 1479-6694 |
| Publisher: | Future Medicine |
| Date Published: | 2025-01-01 |
| Start Page: | 303 |
| End Page: | 311 |
| DOI: | 10.1080/14796694.2024.2441101 |
| PROVIDER: | EBSCOhost |
| PROVIDER: | cinahl plus with full text |
| PMCID: | PMC11792820 |
| PUBMED: | 39723627 |
| DOI/URL: | |
| Notes: | Source: CINAHL Plus with Full Text |
